Search

Ophthalmic Formulations: Equivalence and Patient Care

Robert Noecker MD, MBA

Show Description +

Robert Noecker, MD, provides an overview of ophthalmic formulations and the affect on patient care. Subjects discussed included; the pros and cons of generic medications versus brand-name formulations, the importance of patients' adherence to prescribed glaucoma therapy in medical outcome, the key barriers to patients' adherence to prescribed glaucoma medical therapy, and effective strategies to ensure that patients receive the medications prescribed and facilitate their appropriate long-term use.
Free CME - To earn up to 2 AMA PRA Category 1 credits, click here.

Posted: 8/23/2010

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Ophthalmic Formulations: Equivalence and Patient Care

Robert Noecker MD, MBA

Robert Noecker, MD, provides an overview of ophthalmic formulations and the affect on patient care. Subjects discussed included; the pros and cons of generic medications versus brand-name formulations, the importance of patients' adherence to prescribed glaucoma therapy in medical outcome, the key barriers to patients' adherence to prescribed glaucoma medical therapy, and effective strategies to ensure that patients receive the medications prescribed and facilitate their appropriate long-term use.
Free CME - To earn up to 2 AMA PRA Category 1 credits, click here.

Posted: 8/23/2010

Please log in to leave a comment.

More in Glaucoma

Achieving Success in Interventional Glaucoma

Achieving Success in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Case Study: Interventional Glaucoma in the Real World

Case Study: Interventional Glaucoma in the Real World

Collaborative Care in Interventional Glaucoma

Collaborative Care in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

What Does It Mean to Be Interventional?

What Does It Mean to Be Interventional?

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO